These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20660430)

  • 21. Procedural and temporal compliance to cervical cancer screening guidelines in a CDC-funded program in Alaska.
    Anderson KJ; Speranza PD
    J Low Genit Tract Dis; 2011 Apr; 15(2):98-104. PubMed ID: 21169865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
    Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adequacy of cervical smears.
    Light AM
    Cytopathology; 1998 Apr; 9(2):138-40. PubMed ID: 9577743
    [No Abstract]   [Full Text] [Related]  

  • 24. Quality assurance in cervical cytology. The Papanicolaou smear. Council on Scientific Affairs.
    JAMA; 1989 Sep 22-29; 262(12):1672-9. PubMed ID: 2671421
    [No Abstract]   [Full Text] [Related]  

  • 25. [Significance of sources of error and quality control in cytologic mass screening].
    Zimmer S; Krahnert U; Munck C
    Zentralbl Gynakol; 1987; 109(4):209-17. PubMed ID: 3591056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [How to read a PAP report?].
    Nieminen P
    Duodecim; 1998; 114(11):1138-43. PubMed ID: 11544696
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of cervical cytology in gynaecological practice.
    Narone JN; Wadhawan S; Narone RK; Wacha DS
    Med J Zambia; 1981 Nov-1982 Jan; 16(1):18-20. PubMed ID: 7186715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated cervical cytology screening--a gilded or gelded Trojan horse?
    du Toit GC
    S Afr Med J; 1996 Sep; 86(9):1138-40. PubMed ID: 8888795
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of endocervical status on the cytologic prediction of cervical intraepithelial neoplasia.
    Mitchell H; Medley G
    Acta Cytol; 1992; 36(6):875-80. PubMed ID: 1449025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The quality of a cervix smear].
    Linthorst G; van Lindert AC
    Ned Tijdschr Geneeskd; 1978 Aug; 122(33):1231-2. PubMed ID: 673061
    [No Abstract]   [Full Text] [Related]  

  • 31. [Colpocytologic screening at the Institute of Gynecology, Obstetrics and Physiopathology of Human Reproduction of the 2d Medical and Surgical Faculty of the University of Naples from January 1978 to December 1985].
    Zarcone R; Cardone G; Mancino T; Coja LM; Barbieri-Vita A; Cardone A
    G Ital Oncol; 1987; 7(2-3):109-13. PubMed ID: 3505906
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparison of monolayer specimens and conventional smears].
    Jensen ML; Fuursted PB; Svanholm H
    Ugeskr Laeger; 2001 Feb; 163(9):1270-5. PubMed ID: 11258251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocervical cells on Pap smears.
    Hawkins R
    J Fam Pract; 1996 Aug; 43(2):114. PubMed ID: 8708612
    [No Abstract]   [Full Text] [Related]  

  • 34. Cervical cytology screening: experience of a general hospital.
    Sargeant EJ; Qizilbash AH; Johnson FL
    Can Med Assoc J; 1977 Nov; 117(9):1026-7. PubMed ID: 912627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing terminology and screening recommendations in cervical cytology screening programs.
    Robertson DI; Srivannaboon S; Pairwuti S
    J Med Assoc Thai; 1992 Jan; 75 Suppl 1():90-3. PubMed ID: 1402489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cervical cytology.
    McCrory DC; Matchar DB; Bastian L; Datta S; Hasselblad V; Hickey J; Myers E; Nanda K
    Evid Rep Technol Assess (Summ); 1999 Jan; (5):1-6. PubMed ID: 11925972
    [No Abstract]   [Full Text] [Related]  

  • 37. A 21-year-old woman with atypical squamous cells of undetermined significance.
    Sawaya GF
    JAMA; 2005 Nov; 294(17):2210-8. PubMed ID: 16264163
    [No Abstract]   [Full Text] [Related]  

  • 38. The effectiveness of cytological rescreening in the reduction of false negative/positive Pap reports.
    Cernescu EC; Anton G; Ruţă S; Cernescu C
    Roum Arch Microbiol Immunol; 2013; 72(2):93-104. PubMed ID: 24187808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gynecological screening or cervical screening? Conflicts between clinical and public health viewpoints].
    Döbrőssy L; Kovács A; Budai A; Cornides A
    Orv Hetil; 2012 Aug; 153(33):1302-13. PubMed ID: 22890177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of cytological cervical screening and its changing role in the future.
    Herbert A
    Cytopathology; 2010 Dec; 21(6):355-8. PubMed ID: 21059123
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.